Results 141 to 150 of about 10,682,737 (276)
Background: Hepatic mass lesions encompass a wide range of benign and malignant neoplasms. Differentiating primary liver malignancies from metastatic tumors is crucial for patient management.
Alo A Ayeh +2 more
doaj +1 more source
Although carbohydrate antigen (CA) 19-9 is a useful tumor marker for pancreatic cancer, it can also become elevated from a variety of benign and malignant conditions.
Cardinal, J S +2 more
core +1 more source
Bridging the translational gap in clinical nanomedicine: From rational design to clinical reality
Nanotechnology offers a multi‐faceted approach to modern healthcare, encompassing high‐sensitivity diagnostic imaging, innovative vaccine delivery, and targeted therapeutics. This review explores how these nanomedicine applications address critical challenges in cancer recurrence and the treatment of neurologic and respiratory diseases to combat rising
Ahmed H. Ghonaim +9 more
wiley +1 more source
NILAI DIAGNOSTIK CARBOHYDRATE ANTIGEN 19-9 DAN CARCINOEMBRYONIC ANTIGEN SERUM PADA KANKER KOLOREKTAL [PDF]
Latar Belakang: Kanker kolorektal merupakan kanker kedua terbanyak pada laki-laki dan keempat terbanyak pada perempuan di Indonesia. Metode diagnostik tahap awal sangat dibutuhkan karena kanker kolorektal sering ditemukan pada tahap yang sudah ...
Wella, Novile Izora
core +1 more source
Oral microbial homeostasis, a dynamic host‐microbe balance, is vital in infectious diseases. Conventional antibiotics often disrupt this homeostasis, spurring interest in nanomaterials for oral microbial homeostasis rebalancing. This review outlines nanomaterial strategies across three ecological levels (population/community, ecosystem, and cross ...
Chen Hu +10 more
wiley +1 more source
Key Clinical Message Serum carbohydrate antigen 19‐9 (CA19‐9) is used for recurrence surveillance in patients with resected pancreatic ductal adenocarcinoma (PDAC).
Steve D. Pendry +4 more
doaj +1 more source
Carcinoembryonic antigen and carbohydrate antigen 19-9 serum levels in non-small cell lung cancer
Purpose: Τo investigate the potential diagnostic and prognostic role of carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9) serum levels in non-small cell lung cancer (NSCLC).
Tsoukalas N., Kostakis I.D., Giaginis C., Tolia M., Galanopoulos M., Kiakou M., Aravantinou-Fatorou E., Tsapakidis K., Baxevanos P., Litos I., Tzouda V., Tzovaras A., Kyrgias G., Tsiambas E., Theocharis S.
core
Status and future of recombinant adeno‐associated virus vector manufacturing
Abstract Sixty years of adeno‐associated virus (AAV) research illustrates a trajectory marked by basic science exploration, iterative innovation, persistent challenges, a number of clinical setbacks, as well as commercial therapeutic triumphs. This continual evolution has led to recombinant AAV (rAAV) becoming a cornerstone of modern gene therapy ...
Frank Agbogbo, David Dismuke
wiley +1 more source
Background: Pancreatic ductal adenocarcinoma (PDAC) is associated with high mortality rates therefore early diagnosis and treatment is essential in reducing mortality. Blood tests that can identify high-risk individuals is an unmet medical need.
Alan H.B. Wu +5 more
doaj +1 more source
A Stable Isopterin Mimic of a Potent Bacterial Stimulant of T Cells
A microbial metabolite covalently binds immunological protein MR1 to potently activate specific lymphocytes called MAIT cells, but it is too unstable for biological applications. Here, using synthesis, assays, protein crystallography, and computer modelling, we report a water‐stable analogue that activates reporter cells expressing the MAIT T cell ...
Jeffrey Y. W. Mak +9 more
wiley +1 more source

